about
The ER structural protein Rtn4A stabilizes and enhances signaling through the receptor tyrosine kinase ErbB3High basal Wnt signaling is further induced by PI3K/mTor inhibition but sensitive to cSRC inhibition in mammary carcinoma cell lines with HER2/3 overexpression.BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma.The Therapeutic Challenge of Targeting HER2 in Endometrial CancerA TORC2-Akt Feed-Forward Topology Underlies HER3 Resiliency in HER2-Amplified Cancers.Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.HER3 over-expression and overall survival in gastrointestinal cancersRationally Repurposing Ruxolitinib (Jakafi (®)) as a Solid Tumor TherapeuticSynergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression.Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells.HER3 and LINC00052 interplay promotes tumor growth in breast cancerHER3/ErbB3, an emerging cancer therapeutic target.Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3.Nucleotide-binding mechanisms in pseudokinases.Assessment of Specificity of an Adenovirus Targeted to HER3/4.HER3 as a Therapeutic Target in Cancer.ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology.Nrdp1-mediated ErbB3 degradation inhibits glioma cell migration and invasion by reducing cytoplasmic localization of p27(Kip1).Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin.Hepatitis B virus X protein reduces the stability of Nrdp1 to up-regulate ErbB3 in hepatocellular carcinoma cells.Novel association of DJ-1 with HER3 potentiates HER3 activation and signaling in cancer.Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma.NRG-1 Stimulates Serum DJ-1 Increase in Breast Cancers.Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer.[The HER3/ERBB3 receptor: the dark side of the ERBB planet].Inhibition of HER3 activation and tumor growth with a human antibody binding to a conserved epitope formed by domain III and IV.Estradiol promotes rapid degradation of HER3 in ER-positive breast cancer cell line MCF-7Targeting of HER3 with Functional Cooperative miRNAs Enhances Therapeutic Activity in HER2-Overexpressing Breast Cancer Cells
P2860
Q28910204-E71AB85F-CE5E-424E-9197-3FC6D2D44D5FQ35709435-23AD3EA4-9E2C-4C99-86BC-DB7778F80A49Q35857363-0C17C209-89E1-4B04-9955-DB977C031549Q36064912-CA3F376F-97EA-4B23-BDA5-30A79D09C319Q36359705-AC7AD376-420F-4F6F-A0BD-591FDBDED61EQ36547753-06F746E9-44A3-4D1C-9523-F588733AAA72Q36619051-CD1135DD-C515-42D0-B3C2-D51E2E187246Q36995729-08F98628-D639-4A41-A664-B514CAA81D64Q37190106-4D4E03F5-2D4E-466E-88ED-E3FC5DC92844Q37687371-0098F0A1-B2B2-4AA1-A55A-9825245851DBQ37701632-83EE5BEE-80CC-434D-B66A-6A7892E2588AQ38615197-DCB34239-7C46-48FF-A746-64D6461BCD7BQ38623361-67B88F16-2252-40D6-8F17-DA350A8E0021Q38641286-1E4A9B46-A83E-471A-B864-8F7BC8C46BC5Q38645041-51E5F202-45D1-449D-A8C9-EFB2021AD7FAQ38725101-02A41596-666B-4BD6-8575-5F9E4CB9D3C4Q38729111-BEFEC853-5165-4F4E-82C3-D3326DA4101EQ38862374-B4225C8D-1150-4B33-8083-66642F221CDBQ38935156-DA9682FF-1902-44F2-8737-7EC950954C66Q39499017-22CC10F7-A96B-4B20-8A15-5EC432199D71Q40929586-74ABC188-54D1-4225-B4DB-6B8C39A66B07Q42320213-0C2F6A0C-1683-4A78-B66C-F1DA33275B37Q42393298-1D48A4D0-C482-4D67-9577-8B44FA9F9583Q47722439-2F83728C-554F-49BE-8AE7-CF1A229B7721Q48649855-44E575A3-7870-4228-9B7F-8104354A5101Q54266767-DD91BA9D-3C5A-4033-80E0-3905DDC4CC18Q55000376-2801946E-3466-4837-AA63-08C4995CB13EQ58708224-4E8D32BA-CCE0-4AED-AA65-F7AA5C457D93Q58796351-E273E4D3-1191-4643-8D42-15CE58061732
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Regulation of ERBB3/HER3 signaling in cancer
@ast
Regulation of ERBB3/HER3 signaling in cancer
@en
Regulation of ERBB3/HER3 signaling in cancer
@nl
type
label
Regulation of ERBB3/HER3 signaling in cancer
@ast
Regulation of ERBB3/HER3 signaling in cancer
@en
Regulation of ERBB3/HER3 signaling in cancer
@nl
prefLabel
Regulation of ERBB3/HER3 signaling in cancer
@ast
Regulation of ERBB3/HER3 signaling in cancer
@en
Regulation of ERBB3/HER3 signaling in cancer
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Regulation of ERBB3/HER3 signaling in cancer
@en
P2093
Byung-Kwon Choi
Kalpana Mujoo
Ningyan Zhang
Zhao Huang
Zhiqiang An
P2860
P304
P3181
P356
10.18632/ONCOTARGET.2655
P407
P5008
P577
2014-11-15T00:00:00Z